BMO Capital Markets Reiterates Market Perform Rating for IGM Biosciences (NASDAQ:IGMS)
BMO Capital Markets reiterated their market perform rating on shares of IGM Biosciences (NASDAQ:IGMS – Free Report) in a research report released on Friday morning, Marketbeat reports. BMO Capital Markets currently has a $2.00 price objective on the stock, down from their previous price objective of $21.00. IGMS has been the topic of a number […]
11 Jan 10:48 · The Markets Daily